Zobrazeno 1 - 10 of 113 pro vyhledávání: '"L. Wramner"'
1
Genetic evidence for involvement of adaptive immunity in the development of IgA nephropathy: MHC class II alleles are protective in a Caucasian population
Autor: Sigrid Lundberg, Stefan H. Jacobson, Lars Alfredsson, Iva Gunnarsson, Mai Tuyet Vuong, Emeli Lundström, Anders Fernström, Leonid Padyukov, L. Wramner
Publikováno v: Human Immunology. 74:957-960
There is evidence suggesting that IgA nephropathy (IgAN) is an immunological disease. The role of HLA class II DR beta 1 (DRB1) has previously not been well studied. The aim of our study was to investigate the association of HLA-DRB1 variants with Ig
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::8c6bcd45059de12955fabf7f47475f0f
https://doi.org/10.1016/j.humimm.2013.04.016
Zobrazit plný text záznamu
2
Association of soluble CD89 levels with disease progression but not susceptibility in IgA nephropathy
Autor: Maria Seddighzadeh, Anders Fernström, Leonid Padyukov, Lieu Thi Do, Mai T. Vuong, Lars Å Hanson, Mirjana Hahn-Zoric, Sigrid Lundberg, L. Wramner, Cees van Kooten, Stefan H. Jacobson, Iva Gunnarsson
Publikováno v: Kidney International, 78(12), 1281-1287
The Fc-alpha receptor (Fc alpha R/CD89) is involved in IgA complex formation and may affect the development of IgA nephropathy (IgAN). In this study, we tested the genetic variations of the CD89 gene in relation to disease susceptibility in IgAN and
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b29dc8a955a7d128ca2c88dc38ae8b7c
https://doi.org/10.1038/ki.2010.314
Zobrazit plný text záznamu
5
Bicêtre hospital experience with sirolimus-based therapy in human renal transplantation: the sirolimus European renal transplant study
Autor: Lars Bäckman, C Brattström, Henri Kreis, Dominique Durand, J.-L Touraine, José M. Morales, J. M. Campistol, L. Wramner, K Claesson, R. Y. Calne, Carl-Gustav Groth, Bernard Charpentier, Philippe Lang
Publikováno v: Transplantation Proceedings. 35:S58-S61
In 11 European centers, first cadaveric renal allograft recipients were randomized to CsA (n = 42) or sirolimus (n = 41). Dosing of these agents was concentration-controlled and open-labeled. All patients received corticosteroids and azathioprine. At
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::ce1bde854dcb67c5edcadc303deb7622
https://doi.org/10.1016/s0041-1345(03)00213-6
Zobrazit plný text záznamu
6
SIROLIMUS IN ASSOCIATION WITH MYCOPHENOLATE MOFETIL INDUCTION FOR THE PREVENTION OF ACUTE GRAFT REJECTION IN RENAL ALLOGRAFT RECIPIENTS12
Autor: José M. Morales, Jean-Paul Squifflet, Georges Mourad, José-Mria Grinyo, F. Berthoux, Josep M. Campistol, Walter Land, L. Wramner, Jean-Marc Cisterne, Daniel Abramowicz, Henri Kreis, C Brattström, P. Vialtel, Yvon Lebranchu
Publikováno v: Transplantation. 69:1252-1260
Introduction. A previous trial in renal transplantation comparing sirolimus (rapamycin) to cyclosporine (CsA) ina triple-drug therapy regimen with azathioprine and corticosteroids found that the incidence of acute rejection was similar (approximately
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_________::c825ab9f18ac51c2320e95cc58af7c5b
https://doi.org/10.1097/00007890-200004150-00009
Zobrazit plný text záznamu
8
A comparative, randomized trial of concentration-controlled sirolimus combined with reduced-dose tacrolimus or standard-dose tacrolimus in renal allograft recipients
Autor: W O, Bechstein, L, Paczek, L, Wramner, J-P, Squifflet, A J, Zygmunt, Yves, Vanrenterghem
Publikováno v: Transplantation proceedings. 45(6)
Background The clinical safety and efficacy of sirolimus plus reduced-dose tacrolimus was evaluated in de novo renal allograft recipients enrolled in a comparative, open-label study. Methods One hundred twenty-eight renal allograft recipients were ra
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::0562ab185ed475be78d436c920330c1e
https://pubmed.ncbi.nlm.nih.gov/23953523
Zobrazit plný text záznamu
10
Alteration in T Cell Subset Phenotypes as Cell Markers for Rejection or Long-Term Allograft Acceptance in Allografted Rats Treated with Antithymocyte Globulin
Autor: T Söderström, L. Wramner, Lars Mjörnstedt, B. Kjellson, Michael Olausson
Publikováno v: International Archives of Allergy and Immunology. 101:431-436
The alterations in the absolute levels of lymphocyte phenotype subsets were measured in a rat model for heart allograft acceptance induced by antithymocyte globulin (ATG). In untreated, allografted rats all T lymphocytes decreased with 50% within 3 d
Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::dadae9741c377105fd6d664688aab10c
https://doi.org/10.1159/000236487
Zobrazit plný text záznamu

Vyhledávací nástroje:

Upřesnit hledání

Omezení vyhledávání
Plný text Recenzováno Digitální knihovna AV ČR
Zdroje